Schooner Capital is a private investment firm.
Business Model:
Revenue: $10.6M
Employees: 11-50
Address: 60 South St
City: Boston
State: MA
Zip: 02111
Country: US
Schooner Capital is a private investment office. The firm has no outside limited partners and approaches all investments with a long-term perspective.
Contact Phone:
+16179635200
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2017 | Censinet | Seed Round | 2M |
4/2019 | Censinet | Series A | 7.8M |
4/2011 | Best Doctors | Venture Round | 20M |
1/2023 | Censinet | Venture Round | 0 |
4/2016 | Spotted | Seed Round | - |
2/2022 | SeLux Diagnostics | Series C | 0 |
9/2015 | Zixi | Venture Round | - |
1/2012 | SHIFT | Venture Round | - |
9/2019 | Zippity | Seed Round | 0 |
1/2015 | Fashion Project | Series A | 0 |
10/2018 | SRS Medical Systems | Venture Round | - |
12/2017 | SRS Medical Systems | Venture Round | - |
3/2016 | Maxwell Health | Series C | 0 |
12/2014 | Maxwell Health | Series B | 26.4M |
6/2019 | Commonwealth Fusion | Series A | 0 |
7/2013 | Mimetogen Pharmaceuticals | Venture Round | 0 |
2/2017 | MediaSilo | Venture Round | 7M |
12/2020 | Cullinan Oncology | Series C | 131.2M |
10/2022 | Breezeway | Series B | 15M |
7/2022 | Bento | Series A | 0 |
12/2018 | SeLux Diagnostics | Series B | 25M |
6/2010 | Seventh Generation | Venture Round | - |
4/2013 | Fashion Project | Seed Round | 1.8M |
6/2013 | CustomMade | Series B | 0 |
1/2016 | 4G Clinical | Series A | 2.5M |
9/2021 | MarginEdge | Series B | 0 |
12/2021 | Commonwealth Fusion | Series B | 0 |
5/2020 | Commonwealth Fusion | Series A | 0 |
6/2021 | JETCOOL Technologies | Venture Round | - |
11/2018 | Remedy Plan Therapeutics | Venture Round | 1.5M |
10/2007 | StyleFeeder | Seed Round | 1M |
4/2014 | Topokine Therapeutics | Venture Round | - |
10/2016 | 4G Clinical | Series A | 5M |
1/2011 | IndoStar Capital | Venture Round | - |
11/2020 | Zippity | Seed Round | 0 |
1/2016 | Cartesian Therapeutics | Venture Round | - |
1/2008 | StyleFeeder | Series A | 2M |
1/2017 | F&a;B Asia | Venture Round | - |
1/2013 | MediaSilo | Series A | 2.3M |
7/2017 | Millstone Medical | Private Equity Round | - |
8/2020 | Breezeway | Series A | 0 |
5/2014 | RailComm | Series B | - |
6/2015 | Emerald Cloud Lab | Venture Round | 20.6M |
4/2011 | Zixi | Venture Round | 4M |
2/2016 | Cyft | Seed Round | - |
5/2016 | eXIthera Pharmaceuticals | Series B | 10M |
8/2014 | eXIthera Pharmaceuticals | Venture Round | 6M |
8/2017 | eXIthera Pharmaceuticals | Venture Round | - |
7/2010 | SRS Medical Systems | Venture Round | 3.8M |
1/2012 | Nanoscale Powders | Venture Round | - |
1/2021 | Wren Therapeutics | Venture Round | 17M |
1/2017 | East Point Capital | Venture Round | - |
4/2012 | CustomMade | Series B | 4M |
3/2014 | Emerald Cloud Lab | Venture Round | 6M |
11/2013 | Seventh Generation | Venture Round | - |
10/2006 | Top10 Media | Venture Round | 3.5M |
4/2018 | SpottedRisk, Inc. | Series A | 3.7M |
7/2022 | Bento | Series A | 0 |
2/2022 | SeLux Diagnostics | Series C | 0 |
12/2021 | Commonwealth Fusion | Series B | 0 |
9/2021 | MarginEdge | Series B | 0 |
6/2021 | JETCOOL Technologies | Venture Round | - |
1/2021 | Wren Therapeutics | Venture Round | 0 |
12/2020 | Cullinan Oncology | Series C | 0 |
11/2020 | Zippity | Seed Round | 0 |
8/2020 | Breezeway | Series A | 0 |
5/2020 | Commonwealth Fusion | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|